CEO: Selim Ghorayeb
Products: Cardiometabolic, gastroenterology, infectiology, neurology, rheumatology, urology, immunology, cardiology, pain and inflammation,……
Output and sales: Output increased by 30-35 percent over the 2018-2021 period. The value of sales in terms of real dollars remained basically unchanged over the period due to more focus on the local market where prices are comparatively lower than in export markets.
Inched down a bit to $18-20 million due to measures taken by some Gulf countries including Saudi Arabia. Besides, all six GCC countries, Algorithm
